HOME >> MEDICINE >> NEWS
UK and other European countries should introduce universal childhood hepatitis B vaccination

Children in the UK and seven other European countries should be universally vaccinated against hepatitis B to eliminate the major public-health impact of this disease, according to a Review published in the June issue of The Lancet Infectious Diseases.

Infection with hepatitis B causes between 500,000 and 1.2 million deaths per year worldwide, with around 22,000 of these deaths occurring across Europe. Hepatitis B is also the leading cause of liver cancer.

Dr Jane Zuckerman, Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, London, UK and colleagues reviewed vaccination policies in the UK, Ireland, Finland, Iceland, the Netherlands, Norway, Sweden, and Denmark.

They say: Over 12 years ago, WHO recommended that universal childhood hepatitis B vaccination be implemented globally. Despite this, Denmark, Finland, Iceland, Ireland, the Netherlands, Norway, Sweden, and the UK adopt an at-risk strategy.

At-risk vaccination programmes mean only those people at the highest risk of contracting the disease, e.g. immigrant communities, are vaccinated.

The authors add: Although all eight countries are classed as having low endemicity, factors such as increased travel and integration of immigrant communities are increasing the number of at-risk individuals in these countries.

Under-reporting of hepatitis B cases is a problem, even in industrialised countries. The authors say: The annual incidence of hepatitis B in England is reported to be 600 cases. However, over the past four years, the true incidence is thought to have been nearer 6,000 cases, mainly because of immigration of hepatitis B-positive individuals from areas of high endemicity.

The Review also examines the role of drug users, short- and long-haul travellers, and tattoos and body piercing.

The authors say that the advantages of a universal vaccination programme include that it is the
'"/>

Contact: Dr. Jane Zuckerman
j.zuckerman@medsch.ucl.ac.uk
44-779-887-6445
Lancet
5-Jun-2007


Page: 1 2

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
3. Borderline personality disorder shows improvements with intensive psychotherapy
4. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
5. Chemotherapy may enhance the effectiveness of brain tumor vaccines
6. Brain-boosting pill alleviates post-chemotherapy fogginess
7. Adding radioimmunotherapy to chemo may help patients with lymphoma
8. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
9. Medical management of another condition may not lead to early cancer diagnosis
10. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
11. New mothers often not asked about depression, UNC survey finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology:
Cached News: